IRCT20191211045691N2已完成3 期
Evaluation of the efficacy and safety of Doxycycline in combination with standard treatment in Covid-19 patients: a clinical trial
Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Minimum age 18 and maximum age 80 years
- •Signing up the informed consent form
- •Do not take ?doxycycline during the past 5 days
- •Patients suspected of covid-19 based on clinical signs and manifestations of CT scan
- •Candidate for outpatient treatment
排除标准
- •Patients hospitalized
- •Patients with hemodynamic instability
- •Patients with a history of allergic reaction or allergy to doxycycline
- •Second and third trimesters of pregnancy
研究者
相似试验
已完成
3 期
Effect of Doxycycline on clinical improvement and outcome in patients with COVID-19IRCT20201117049427N1Iran University of Medical Sciences180
尚未招募
2 期
Evaluation of the effectiveness of doxycycline in the treatment of outpatients with Covid-19IRCT20160523028008N16Hamedan University of Medical Sciences88
尚未招募
2 期
Treatment of periodontal defects with a combination of autologous blood products and antibioticsCTRI/2024/07/070193DOGIPARTHI MOUNICA
进行中（未招募）
不适用
Efficacité et tolérance de la doxycycline dans le traitement des maladies humaines à prions : un essai randomisé en double aveugle versus placebo - DOXYPRIONSEUCTR2007-005553-34-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
已完成
不适用
The effect of doxycycline and zinc sulfate in acneacne vulgaris.Disease of skin appendagesIRCT201105156493N1Tabriz University of Medical Sciences80